article thumbnail

Exploring Melbourne’s booming life sciences sector

Pharmaceutical Technology

Australia is fast becoming the place to be for innovative life sciences companies, as proved by Melbourne’s latest FDI wins from the likes of BioNTech and Moderna.

article thumbnail

UK life science industry optimistically embraces Labour victory

Pharmaceutical Technology

The UK life science industry is crossing its fingers as a Labour government takes the reigns following 14 years of Conservative rule.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Industry calls for boosting innovation and investment in NCEs and NBEs to propel life sciences growth

AuroBlog - Aurous Healthcare Clinical Trials blog

As the Union Budget approaches, the life sciences sector anticipates substantial support to enhance innovation and investment in the development of new chemical entities (NCEs) and new biological entities (NBEs). The life sciences sector in India has shown remarkable resilience […]

article thumbnail

Digital dilemma in UK’s life sciences job market

Pharmaceutical Technology

In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.

article thumbnail

Podcast #2: Doing Digital Deals in Life Sciences | Information Governance

Pharmaceutical Technology

In this series, life sciences industry M&A veteran John Easton will discuss how digital deals differ from traditional life science deals

article thumbnail

Podcast #3: Doing Digital Deals in Life Sciences | Defining & Valuing the Asset

Pharmaceutical Technology

In this series, life sciences industry M&A veteran John Easton will discuss how digital deals differ from traditional life science deals

article thumbnail

How life sciences benefits from broader healthcare transformation

Bio Pharma Dive

Digital transformation has much to offer life sciences as well as healthcare — and the synergies between the two can further optimize the power of digital health, clinical trials and patient outcomes.